EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Effectiveness of the Composite Autonomic Symptom Score 31 Scale in Evaluating Autonomic Dysfunction in Diabetic Peripheral Neuropathy: A Comparative Study Using Autonomic Function Testing as Reference

Dube Suchitra, Sandip M. Hulke, Santosh Laxman Wakode, Lakshya Bhardwaj

Journal of Public Health and Primary Care · 2026-09 · 7 (3) · 166-170

DOI: 10.4103/jphpc.jphpc_1_26 ↗

At a glance

Journal article in Journal of Public Health and Primary Care, published online on 2026-08-17. Written by Dube Suchitra and 3 co-authors. 15 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Autonomic dysfunction is a common yet underdiagnosed complication of diabetic peripheral neuropathy (DPN), contributing to increased morbidity. Early detection is critical for prompt management. The Composite Autonomic Symptom Score 31 (COMPASS-31) is a self-administered questionnaire developed to assess autonomic symptoms. However, its validity compared to standardized autonomic function testing (AFT) has not been fully established in diabetic populations. Materials and Methods: This observational cross-sectional study was conducted at AIIMS Bhopal on 72 patients with type 2 diabetes mellitus of more than 1-year duration. Each participant underwent evaluation using the COMPASS-31 questionnaire, heart rate variability (HRV) parameters, and cardiovascular reflex tests according to Ewing’s criteria. Diagnostic accuracy measures – sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) – were calculated using AFT as the reference standard. Correlation analysis was performed between COMPASS-31 scores and HRV parameters.

Results

Autonomic dysfunction was identified in 72% of the study population through AFT. The COMPASS-31 scale was abnormal in 36% of cases. It showed a sensitivity of 34.61%, specificity of 60%, PPV of 69.23%, and NPV of 26.08%. Significant positive correlations were found between COMPASS-31 scores and several HRV indices ( r > 0.5, P < 0.001), indicating its potential utility in assessing autonomic symptoms.

Conclusions

While the COMPASS-31 scale exhibits moderate diagnostic accuracy, it offers a feasible, noninvasive method for preliminary screening of autonomic dysfunction in DPN, particularly in settings lacking access to comprehensive autonomic testing.

Cite

APA

Suchitra, D., Hulke, S. M., Wakode, S. L., & Bhardwaj, L. (2026). Effectiveness of the Composite Autonomic Symptom Score 31 Scale in Evaluating Autonomic Dysfunction in Diabetic Peripheral Neuropathy: A Comparative Study Using Autonomic Function Testing as Reference. Journal of Public Health and Primary Care, 7(3), 166-170. https://doi.org/10.4103/jphpc.jphpc_1_26

Vancouver

Suchitra D, Hulke SM, Wakode SL, Bhardwaj L. Effectiveness of the Composite Autonomic Symptom Score 31 Scale in Evaluating Autonomic Dysfunction in Diabetic Peripheral Neuropathy: A Comparative Study Using Autonomic Function Testing as Reference. Journal of Public Health and Primary Care. 2026;7(3):166-170. doi:10.4103/jphpc.jphpc_1_26

BibTeX
@article{Suchitra2026,
  author = {Suchitra, Dube and Hulke, Sandip M. and Wakode, Santosh Laxman and Bhardwaj, Lakshya},
  title = {Effectiveness of the Composite Autonomic Symptom Score 31 Scale in Evaluating Autonomic Dysfunction in Diabetic Peripheral Neuropathy: A Comparative Study Using Autonomic Function Testing as Reference},
  journal = {Journal of Public Health and Primary Care},
  year = {2026},
  volume = {7},
  number = {3},
  pages = {166--170},
  doi = {10.4103/jphpc.jphpc_1_26}
}
Start for free →